Vestaron Corp. Appoints Dr. John Sorenson as CEO

Vestaron Corp. Appoints Dr. John Sorenson as CEO 
KALAMAZOO, MI -- (Marketwired) -- 01/07/14 --  Vestaron Corporation,
a venture-backed agricultural company, announced today that John
Sorenson, Ph.D., has been appointed the company's Chief Executive
Officer. Dr. Sorenson has served as Chairman of the Board since 2011
and has served as its interim CEO since September. Keith Gillard of
Pangaea Ventures will assume the chairmanship of the Board of
Directors. 
"I'm very pleased to move from interim to permanent CEO at a very
exciting time in our company's history. Field trials of our
biopesticide have shown very good efficacy, and the development of
GMO and synthetic versions of it are progressing exceptionally well.
2014 will see us move from an R&D company to a commercial product
company. I couldn't be prouder of the progress the team has made as
we move toward commercialization of our first product," said
Sorenson. 
Dr. Sorenson began his career as Assistant and Associate Professor of
Genetics at North Carolina State University. He then moved to the
Asgrow Seed Company and held positions in biotechnology, research,
and eventually became Head of its Global Vegetable Seeds business.
Dr. Sorenson then moved to the Sandoz (now Syngenta) seeds business,
where he held positions of President of Rogers Seed Company,
President of Syngenta Seeds, Inc. (the company's North American seeds
business), and President of Biotechnology for Syngenta. He has served
on the Boards of Directors of the American Seed Trade Association,
the United Fresh Fruit and Vegetable Association, the National
Council of Commercial Plant Breeders, and the American Seed Research
Foundation. He has served on the Vestaron Board of Directors since
2008. 
Mr. Gillard is General Partner at Pangaea Ventures Ltd., and began
his career as an entrepreneur, founding a number of companies before
joining Mitsubishi Corporation to establish and manage its Canadian
venture capital activities. He later moved to Silicon Valley to
become President of BASF Venture Capital America Inc., responsible
for the chemical and agricultural giant's North American venture
capital activities. Mr. Gillard joined Pangaea in 2010 and has served
on the Vestaron Board of Directors since 2012. 
Vestaron is commercializing a new generation of biopesticides using
natural peptides originally discovered in spiders. Vestaron's
products have unique modes of action and are highly effective against
crop damaging pests, yet have proven harmless to non-target species
including humans. Target markets include agriculture, animal health,
and specialty non-crop uses such as household insects. Vestaron
products are ideally suited for the environmentally conscious 21st
century. For more information, visit www.vestaron.com.  
Contact:
Nancy K. Newman
269-372-3108
nknewman@vestaron.com 
 
 
Press spacebar to pause and continue. Press esc to stop.